Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
09/2011
09/21/2011EP1798222B1 Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery
09/21/2011CN102197037A Morphinan compounds
09/21/2011CN102197031A Substituted 5-aminopyrazoles and use thereof
09/21/2011CN102196809A Agent for treatment of diabetic nephropathy
09/21/2011CN102190673A Rare earth/ionic liquid luminescent material
09/21/2011CN102190660A N-F Troger type quaternary ammonium salt and preparation method thereof
09/21/2011CN102190658A Structural analogue of antineoplastic marine natural product ecteinascidins
09/21/2011CN102190657A Process for preparing moxifloxacin and salts thereof
09/21/2011CN102190638A Biaryl alcohol diamine compound, its pharmaceutical composition, preparation method and application
09/21/2011CN101597289B 2-tryptophanyl-Beta-tetrahydric carboline-3-formyol amino-acid benzyl ester and preparation method and application thereof
09/21/2011CN101268074B 5-amino-4-hydroxy-7- (imidazo [1,2-A] pyridin-6- ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension
09/20/2011US8022214 N,N-disubstituted perylene-3,4:9,10-bis(dicarboximides), used as n-type junctions, integrated in various device designs including, circuits, thin film transistors, light-emitting diodes, photoelectric cells, detectors and capacitors
09/20/2011US8022207 Compound having affinity to amyloid
09/20/2011US8022206 Furo[3,2-C]pyridines
09/20/2011US8022077 Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof
09/20/2011US8022075 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition
09/20/2011US8022065 Purine derivatives as kinase inhibitors
09/20/2011US8022057 MAPK/ERK kinase inhibitors
09/20/2011US8022047 Combination anticancer agents
09/20/2011CA2617957C Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds
09/20/2011CA2583737C Compounds and compositions as protein kinase inhibitors
09/20/2011CA2516934C Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives
09/20/2011CA2476067C Carbonylamino-derivatives as novel inhibitors of histone deacetylase
09/15/2011WO2011112995A1 Imidazopyridines syk inhibitors
09/15/2011WO2011112816A1 Oral formulations and lipophilic salts of methylnaltrexone
09/15/2011WO2011112769A1 Compounds for the treatment of hepatitis c
09/15/2011WO2011112731A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease
09/15/2011WO2011112186A1 Compounds for the treatment of hepatitis c
09/15/2011WO2011111875A1 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof
09/15/2011WO2011110954A1 Highly pure varenicline or a pharmaceutically acceptable salt thereof substantially free of methylvarenicline impurity
09/15/2011WO2011110479A1 Process for the manufacture of 5-halogenated-7-azaindoles
09/15/2011WO2011110183A1 Azaisoquinolinone derivatives as nk3 antagonists
09/15/2011WO2011109932A1 Novel process for the manufacture of 5-halogenated-7-azaindoles
09/15/2011WO2011041989A3 Tricyclic and tetracyclic systems with activity on the central-nervous and vascular systems
09/15/2011US20110224439 Process for Manufacturing 5-Chloromethyl-2,3-Pyridine Dicarboxylic Acid Anhydrides
09/15/2011US20110224438 Novel process for the manufacture of 5-halogenated-7-azaindoles
09/15/2011US20110224437 Process for preparing varenicline, varenicline intermediates, and pharmaceutically acceptable salts thereof
09/15/2011US20110224403 Method of making a cyclic guanidine from dicyandiamide and coating compositions containing same
09/15/2011US20110224250 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient
09/15/2011US20110224249 Novel Hydrate Form
09/15/2011US20110224248 Azaquinolones that inhibit prolyl hydroxylase
09/15/2011US20110224247 Azaisoquinolinone derivatives as nk3 antagonists
09/15/2011US20110224231 Novel Lactams as Beta Secretase Inhibitors
09/15/2011US20110224199 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues
09/15/2011US20110224197 Pyrimidines and pyridines useful as inhibitors of protein kinases
09/15/2011US20110224195 Heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
09/15/2011US20110224191 Substituted Pyrrolo[2,3-b]-Pyridines and -Pyrazines
09/15/2011US20110224190 Piperidin-4-yl azetidine derivatives as jak1 inhibitors
09/15/2011US20110224187 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof
09/15/2011US20110224155 Modulation of chemosensory receptors and ligands associated therewith
09/15/2011US20110224079 Spiroheterocyclic n-oxyamides as pesticides
09/15/2011US20110223132 Isothiazoloquinolones and related compounds as anti-infective agents
09/15/2011US20110220884 Compound for organic thin-film transistor and organic thin-film transistor using same
09/15/2011CA2792769A1 Imidazopyridines syk inhibitors
09/15/2011CA2792539A1 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof
09/15/2011CA2791460A1 Highly pure varenicline or a pharmaceutically acceptable salt thereof substantially free of methylvarenicline impurity
09/14/2011EP2365735A2 Luminescent element material and luminescent element comprising the same
09/14/2011EP2364983A2 Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same
09/14/2011EP2364982A1 Spiro-piperidine compounds as chemokine receptor antagonists and medicinal use thereof
09/14/2011EP2364981A1 Salts and crystalline forms of 2-methyl-2-[4- (3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile
09/14/2011EP2364976A1 S1P receptor modulating compounds and use thereof
09/14/2011EP2364970A1 Processes and intermediates
09/14/2011EP2364705A2 Modulators of muscarinic receptors
09/14/2011EP2364313A1 Aza-benzimidazolone chymase inhibitors
09/14/2011EP2364311A1 Tropane urea derivatives, preparation thereof and therapeutic application thereof as modulators of the activity of 11betahsd1
09/14/2011EP2364308A1 Pyrazine compounds as phosphodiesterase 10 inhibitors
09/14/2011EP2364306A1 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
09/14/2011EP2364301A1 Enantiomerically enriched aryloazol- 2 -yl cyanoethylamino paraciticidal compounds
09/14/2011EP2364298A1 Quinolone compound and pharmaceutical composition
09/14/2011EP2235017B1 Spiroindolinone derivatives as anticancer agents
09/14/2011EP2229389B1 Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
09/14/2011EP2225241B1 Derivatives of N-phenyl-imidazo-(1,2-A)-pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
09/14/2011EP2164847B1 3-aza-bicyclo[3.3.0]octane compounds
09/14/2011EP2139892B1 Substituted pyrimidodiazepines useful as plk1 inhibitors
09/14/2011EP1896421B1 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
09/14/2011EP1874769B1 Novel aza- heterocycles serving as kinase inhibitors
09/14/2011EP1727820B1 Amine derivatives with tyrosinkinase inhibiting activity
09/14/2011EP1689387B1 Bicyclic inhibitors of mek and methods of synthesis thereof
09/14/2011EP1559716B1 Pyrazolonaphthyridine derivative
09/14/2011EP1346982B1 Vla-4 inhibitors
09/14/2011CN1642551B Inhibitors of histone deacetylase
09/14/2011CN1612861B Ecl labels having improved non-specific binding properties, methods of using and kits containing the same
09/14/2011CN102186851A Triazolopyridine compounds as pim kinase inhibitors
09/14/2011CN102186850A Phenanthroindolizidine derivative and nfkb inhibitor containing same as active ingredient
09/14/2011CN102186849A Phenanthroindolizidine compound and nf?b inhibitor containing same as active ingredient
09/14/2011CN102183589A Method for detecting contents of dolasetron isomer and salt thereof
09/14/2011CN102180878A Dolasetron isomer or salt thereof, preparation method for the Dolasetron isomer or salt thereof and application of the Dolasetron isomer or salt thereof
09/14/2011CN102180877A Synthetic process of imidazo phenanthroline compound
09/14/2011CN102180876A New preparation method for Tadalafei crystal form I
09/14/2011CN102180875A Preparation method of triazolopyridine derivative
09/14/2011CN102180874A Synthetic process method for azabicyclo medicinal intermediates
09/14/2011CN102180873A Functional ionic liquid and preparation method thereof
09/14/2011CN101597293B Method for preparing purrocoline derivatives by microwave reaction
09/14/2011CN101541798B Process for production of mirtazapine
09/14/2011CN101528745B Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes
09/14/2011CN101450947B 7-(3-oximido-4-amido-4-alkyl-1-piperidine)quinoline carboxylic acid derivates and preparation method thereof
09/14/2011CN101423517B Gamma-carbolines derivates as well as preparation method and application thereof
09/14/2011CN101014601B Preparation of 9-hydroxy-3- (2-hydroxyethyl) -2-methyl-4h-pyrid0[1, 2-a] pyrimidin-4-one and crystals thereof
09/13/2011US8017781 Azaindazoles useful as inhibitors of kinases
09/13/2011US8017779 Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines